Year archive

NAVCO Pharmaceuticals — 2024 filings

All 27 regulatory filings released by NAVCO Pharmaceuticals (NAV) in 2024, sourced directly from the official regulator.

27 Filings

2024 Period

2024 filings (27)

Filing	Released	Lang
News release - English.pdf Regulatory Filings	2024-09-25	English
52-109FV2 - Certification of interim filings - CFO (E).pdf Regulatory Filings	2024-09-10	English
52-109FV2 - Certification of interim filings - CEO (E).pdf Regulatory Filings	2024-09-10	English
News release - English.pdf Regulatory Filings	2024-09-03	English
News release - English.pdf Regulatory Filings	2024-06-05	English
52-109FV2 - Certification of interim filings - CFO (E).pdf Regulatory Filings	2024-06-03	English
52-109FV2 - Certification of interim filings - CEO (E).pdf Regulatory Filings	2024-06-03	English
Form of proxy - English.pdf AGM Information	2024-05-15	English
Management information circular - English.pdf Proxy Solicitation & Information Statement	2024-05-15	English
Notice of meeting - English.pdf AGM Information	2024-05-15	English
Other.pdf Regulatory Filings	2024-05-15	English
Other securityholders documents - English.pdf Regulatory Filings	2024-05-14	English
News release - English.pdf Regulatory Filings	2024-04-13	English
Statement of executive compensation (form 51-102F6V) - English.pdf Remuneration Information	2024-03-29	English
Notice of the meeting and record date - English.pdf AGM Information	2024-03-28	English
News release - English.pdf Share Issue/Capital Change	2024-03-14	English
52-109FV2 - Certification of interim filings - CEO (E).pdf Regulatory Filings	2024-02-28	English
52-109FV1 - Certification of annual filings - CFO (E).pdf Regulatory Filings	2024-01-30	English
52-109FV1 - Certification of annual filings - CEO (E).pdf Regulatory Filings	2024-01-30	English
Annual MD&A - English.pdf Management Reports	2024-01-30	English
AB form 13-501F1 (class 1 and 3B reporting issuers - participation fee).PDF Regulatory Filings	2024-01-30	English
ON form 13-502F1 (class 1 and 3B reporting issuers - participation fee).PDF Regulatory Filings	2024-01-30	English
Audited annual financial statements – English.pdf Annual Report	2024-01-30	English
Material change report - English.pdf Regulatory Filings	2024-01-29	English
News release - English.pdf M&A Activity	2024-01-19	English
News release - English.pdf Regulatory Filings	2024-01-18	English
News release - English.pdf M&A Activity	2024-01-18	English